Citation: | ZHENG Qian, YU Caiyao, LI Haoyun, FENG Zhanhui. Systemic lupus erythematosus and myasthenia gravis: a bidirectional Mendelian randomization study[J]. Chinese Journal of General Practice, 2024, 22(12): 2020-2024. doi: 10.16766/j.cnki.issn.1674-4152.003788 |
[1] |
王玲玲, 扶琼, 吴春梅. 外周血浆细胞比值在系统性红斑狼疮病情监测中的临床价值[J]. 临床内科杂志, 2023, 40(8): 535-539. doi: 10.3969/j.issn.1001-9057.2023.08.009
WANG L L, FU Q, WU C M. Clinical value of peripheral plasma cell ratio in monitoring the condition of systemic lupus erythematosus[J]. Journal of Clinical Internal Medicine, 2023, 40(8): 535-539. doi: 10.3969/j.issn.1001-9057.2023.08.009
|
[2] |
GARCÍA ESTÉVEZ D A, PARDO FERNÁNDEZ J. Myasthenia gravis. Update on diagnosis and therapy[J]. Med Clin (Barc), 2023, 161(3): 119-127. doi: 10.1016/j.medcli.2023.04.006
|
[3] |
王美萍, 张哲宇, 张圣, 等. 免疫抑制剂治疗重症肌无力伴胸腺异常患者的临床观察研究[J]. 中华全科医学, 2020, 18(12): 2002-2005. doi: 10.16766/j.cnki.issn.1674-4152.001673
WANG M P, ZHANG Z Y, ZHANG S, et al. Clinical observation of immunosuppressive therapy for myasthenia gravis with thymus abnormalities[J]. Chinese Journal of General Practice, 2020, 18(12): 2002-2005. doi: 10.16766/j.cnki.issn.1674-4152.001673
|
[4] |
ALI M, RIAD M, ADHIKARI P, et al. Association between myasthenia gravis and systemic lupus erythematosus as a comorbid state[J]. Cureus, 2021, 13(4): e14719. DOI: 10.7759/cureus.14719.
|
[5] |
ELDAABOSSI S, ALRASHDAN M, ALJANOBI G, et al. A rare association: obesity hypoventilation syndrome with myasthenia gravis and systemic lupus erythematosus, case report[J]. Respir Med Case Rep, 2023, 44(5): 101848. DOI: 10.1016/j.rmcr.2023.101848.
|
[6] |
PATKI A Y, DURGA P, GANGISHETTY A, et al. Myasthenia gravis: an unanticipated cause of failure to wean in a postpartum patient with preexisting systemic lupus erythematosus[J]. Indian J Crit Care Med, 2022, 26(6): 731-732. doi: 10.5005/jp-journals-10071-24228
|
[7] |
YERRAM K, BAISYA R, DEVARASETTI P K. Postpartum myasthenic crisis in a patient with SLE: a case report and literature review[J]. Mediterr J Rheumatol, 2022, 33(4): 449-452. doi: 10.31138/mjr.33.4.449
|
[8] |
KLIMI E, KATAXAKI E. Systemic lupus erythematosus and myasthenia gravis in a male patient: an HLA case investigated[J]. Mediterr J Rheumatol, 2021, 32(3): 285-286. doi: 10.31138/mjr.32.3.285
|
[9] |
JIMÉNEZ-ALONSO J, NAVARRETE-NAVARRETE N, JIMÉNEZ-JÁIMEZ E, et al. Myasthenia gravis and systemic lupus erythematosus: presentation of 5 cases and PubMed review[J]. Neurologia (Engl Ed), 2021, 36(7): 556-557.
|
[10] |
BROADBENT J R, FOLEY C N, GRANT A J, et al. Mendelian Randomization v0.5.0: updates to an R package for performing Mendelian randomization analyses using summarized data[J]. Wellcome Open Res, 2020, 5(12): 252. DOI: 10.12688/wellcomeopenres.16374.2.
|
[11] |
SAKAUE S, KANAI M, TANIGAWA Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes[J]. Nat Genet, 2021, 53(10): 1415-1424. doi: 10.1038/s41588-021-00931-x
|
[12] |
CHIA R, SAEZ-ATIENZAR S, MURPHY N, et al. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study[J]. Proc Natl Acad Sci USA, 2022, 119(5): e2108672119. DOI: 10.1073/pnas.2108672119.
|
[13] |
CHO Y, HAYCOCK P C, SANDERSON E, et al. Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework[J]. Nat Commun, 2020, 11(1): 1010. DOI: 10.1038/s41467-020-14452-4.
|
[14] |
MANUJA N, KUMAR S, ACHARYA S, et al. Simultaneous myasthenic crisis with thyrotoxic crisis in an adult male: an autoimmune overlap[J]. Cureus, 2023, 15(8): e44366. DOI: 10.7759/cureus.44366.
|
[15] |
NAGARAJAN M, MAASILA A T, DHANAPRIYA J, et al. Systemic lupus erythematosus and myasthenia gravis: a rare association[J]. Indian J Nephrol, 2019, 29(1): 62-64. doi: 10.4103/ijn.IJN_12_18
|
[16] |
GARCÍA-ALFONSO C, BERNAL-MACÍAS S, GARCÍA-PARDO Y, et al. Coexistence of systemic lupus erythematosus and myasthenia gravis: an unusual case of polyautoimmunity[J]. Reumatol Clin (Engl Ed), 2020, 16(6): 502-505. doi: 10.1016/j.reuma.2018.08.013
|
[17] |
ZHU Y, WANG B Q, HAO Y H, et al. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases[J]. Front Immunol, 2023, 14(9): 1223322. DOI: 10.3389/fimmu.2023.1223322.
|
[18] |
PAN Z J, ZHU T, LIU Y J, et al. Role of the CXCL13/CXCR5 axis in autoimmune diseases[J]. Front Immunol, 2022, 13(5): 850998. DOI: 10.3389/fimmu.2022.850998.
|
[19] |
LOTFI N, THOME R, REZAEI N, et al. Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update[J]. Front Immunol, 2019, 10(6): 1265. DOI: 10.3389/fimmu.2019.01265.
|
[20] |
LIU X X, MA Q, QIU L, et al. Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis[J]. Clin Immunol, 2020, 216(7): 108462. DOI: 10.1016/j.clim.2020.108462.
|
[21] |
WANG N, YUAN J, KARIM M R, et al. Effects of mitophagy on regulatory T Cell function in patients with myasthenia gravis[J]. Front Neurol, 2020, 11(4): 238. DOI: 10.3389/fneur.2020.00238.
|
[22] |
ELDAABOSSI S, ALRASHDAN M, ALJANOBI G, et al. A rare association: Obesity hypoventilation syndrome with myasthenia gravis and systemic lupus erythematosus, case report[J]. Respir Med Case Rep, 2023, 44(5): 101848. DOI: 10.1016/j.rmcr.2023.101848.
|
[23] |
ZHONG H H, ZHAO C B, LUO S S. HLA in myasthenia gravis: from superficial correlation to underlying mechanism[J]. Autoimmun Rev, 2019, 18(9): 102349. DOI: 10.1016/j.autrev.2019.102349.
|
[24] |
VNLV B, TVRSEN V, JABALAMELI N, et al. Immunogenetics of lupus erythematosus[J]. Adv Exp Med Biol, 2022, 1367(3): 213-257.
|